Oral probiotic to prevent complications after stem-cell transplant
Part of Blood & lymphatic clinical trials.
This Phase 2 study tests an oral “fecal microbiotherapy” treatment given before and around an allogeneic (donor) stem-cell transplant to help prevent transplant-related complications. It may help by improving gut and immune function during the high-risk transplant period.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 50 or older
- You have a blood cancer where a donor stem-cell transplant (alloHCT) is planned using a lower-toxicity conditioning plan
- You recently used wide-spectrum antibiotics within the last 90 days
- Your health is strong enough for the study (Karnofsky score at least 70%)
- A suitable donor is available (sibling, unrelated, or half-matched family donor)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether a fecal microbiota transplant (a processed transplant of gut bacteria) after an allogeneic bone marrow transplant is safe and helpful. Participants may benefit by improving recovery in the gut microbiome during the post-transplant period.
This trial tests whether a special probiotic made from the patient's own gut bacteria and their donor's can help fix gut problems caused by a complication called graft-versus-host disease (aGVHD) after a stem cell transplant. It might help patients who are over 50 and scheduled for a specific type of transplant.
This trial tests whether giving a transplant of healthy gut bacteria (fecal microbiota transplant) before a stem cell transplant can improve outcomes for people with certain blood cancers or bone marrow disorders.
This study looks at changes in your gut bacteria (microbiome) around the time of stem cell transplant. The goal is to understand how these bacteria relate to transplant outcomes, which may help doctors improve care in the future.
This study tests whether a fecal microbiota transplant (FMT) — putting healthy donor bacteria into your gut — can help your immune system recover better after a stem cell transplant. It is for people whose immune markers are still low 6 months after transplant.
This trial tests a standard transplant preparation (chemotherapy and low-dose radiation) followed by a special drug (PTCy) to prevent graft-versus-host disease after a donor stem cell transplant for blood cancers. It may help improve transplant success and reduce complications.
Hear when a new Transplant Complication trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.